StockWatch
·

Waaree Renewable Technologies Ltd Q2 FY26 Results

WAAREERTLQ2 FY26 Results
Filing
MetricValue (₹ Cr)Q1 FY26Q2 FY25
Revenue774.7828.4%47.7%
Total Income779.2128.2%47.6%
Expenditure622.6426.7%35.8%
PBT156.5634.3%125.9%
Net Profit116.3434.7%117.4%
OPM20.39%0.90pp
NPM14.93%0.72pp
EPS11.1634.6%2088.2%
View full financials

Waaree Renewable Technologies Ltd Reports Highest Ever Quarterly Revenue & PAT with 47.73% & 117.40% YoY Growth Respectively

10 Oct 2025 · 10 Oct 2025, 08:46 pm

Summary

Waaree Renewable Technologies Ltd, the EPC arm of the Waaree Group, has announced its unaudited financial results for the quarter and half year ended September 30, 2025. The company reported its highest ever quarterly revenue and PAT with a growth of 47.73% and 117.40% YoY respectively.

Key Highlights

  1. 1

    Revenue from operations for the quarter stood at Rs. 774.78 crores

  2. 2

    Q2 FY26 PAT of Rs. 116.34 crores

  3. 3

    Strong unexecuted orderbook of 3.48 GWp

  4. 4

    Revenue for Q2FY26 stood at Rs. 774.78 crores representing a growth of 47.73% YoY

  5. 5

    EBITDA for Q2FY26 stood at Rs. 157.94 crores representing a growth of 120.69% YoY

  6. 6

    PAT for Q2FY26 stood at Rs. 116.34 crores representing a growth of 117.40% YoY

  7. 7

    Revenue for H1FY26 stood at Rs. 1377.97 crores representing a growth of 81.12% YoY

  8. 8

    Unexecuted order book stands at 3.48 GWp to be executed between 12-15 months

  9. 9

    Bidding pipeline remains robust at 27+ GWp

  10. 10

    Recent Order Wins: 1218 MWp Ground Mounted solar power project and 29.4 MWp Ground Mounted solar power project

Management Comments

M

Mr. Manmohan Sharma

CFO, Waaree Renewable Technologies Limited

We are pleased to report highest ever quarterly revenue of Rs.774.78 crores for Q2 FY26, compared to Rs.524.47 crores in Q2 FY25, delivering a robust growth of 47.73%. The substantial growth in the numbers is a result of our execution capabilities and increasing sector performance.

Informational and educational content only. Not investment advice.